When was Quantum Biosystems founded?

Quantum Biosystems was founded in 2013 and raised its 1st funding round within a year of its incorporation.

Where is Quantum Biosystems located?

Quantum Biosystems is headquartered in Osaka, Japan.

Is Quantum Biosystems a funded company?

Quantum Biosystems is a funded company, having raised a total of $35M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Apr 30, 2013.

When was the latest funding round of Quantum Biosystems?

Quantum Biosystems' latest funding was a $***** Series C round on Nov 30, 2018, with participation from 1 investor. Its primary sector is Genomics. In Japan, the Genomics sector has seen $33.3M in funding in 2026 to date.

Where does Quantum Biosystems rank among its competitors?

Quantum Biosystems ranks 33rd amongst 144 active competitors, of which 44 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Algorithmiq, which secured $21.2M in May, 2026.

Who are the top competitors of Quantum Biosystems?

Quantum Biosystems' top competitors include Nanopore Technologies, PacBio and Illumina. Among them, Algorithmiq secured the most recent funding round in May, 2026.

Quantum Biosystems - 2026 Company Profile, Team, Funding & Competitors

Quantum Biosystems is a series C company based in Osaka (Japan), founded in 2013 by Taniguchi Masateru. It operates as a Developing DNA sequencers based on quantum mechanics. Quantum Biosystems has raised $35M in funding from investors like Mitsubishi UFJ Capital, UTEC and INCJ. The company has 144 active competitors, including 44 funded and 32 that have exited. Its top competitors include companies like Nanopore Technologies, PacBio and Illumina.

Company Details

Quantum Biosystems is developing DNA sequencers based on quantum mechanics. The company claims that its proprietary Quantum Sequencing technology achieves single molecule electrical DNA sequencing by integrating silicon technology and electric detection system. Their platform allows label-free, low-cost, high-throughput, and real-time analysis with no need for complex sample preparation, detection, or analysis.

Website: quantumbiosystems.com
Social
Email ID: *****@quantumbiosystems.com

Key Metrics

Founded Year

2013

Location

Osaka, Japan

Stage

Series C

Total Funding

$35M in 4 rounds

Latest Funding Round

Series C, Nov 30, 2018, $*****

Investors

Mitsubishi UFJ Capital & 6 more

Ranked

33^rd among 144 active competitors

Similar Companies

Nanopore Technologies & 178 more

View Quantum Biosystems' full profile

Quantum Biosystems has raised a total funding of $35M over 4 rounds. Its first funding round was on Apr 30, 2013. Its latest funding round was a Series C round on Nov 30, 2018 for $*****. 1 investor participated in its latest round. Quantum Biosystems has 7 institutional investors.

Here is the list of recent funding rounds of Quantum Biosystems:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 30, 2018	1259495	Series C	2669057	6229234	8666807	4302326
Feb 06, 2015	5986098	Series B	4392515	8903129	5081091	UTEC & 2 more
Feb 20, 2014	2245997	Series A	4447663	1349715	UTEC & 1 more	JAFCO

Access funding benchmarks and valuations. Sign up today!

View details of Quantum Biosystems's funding rounds and investors

The founders of Quantum Biosystems is Taniguchi Masateru.

Here are the details of Quantum Biosystems' key team members:

Taniguchi Masateru: Co-Founder & CSO of Quantum Biosystems.

View details of Quantum Biosystems's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Quantum Biosystems include Nanopore Technologies, PacBio and Illumina. Here is the list of Top 10 competitors of Quantum Biosystems, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nanopore Technologies 2005, Oxford (United Kingdom), Public	Manufacturer of portable and benchtop devices for real-time DNA sequencing	$1.34B	IP Group, GIC & 93 others	75/100
2nd	PacBio 2004, Menlo Park (United States), Public	Developer of instrument systems and software for real-time sequencing of single-molecules	$410M	Deerfield, Kleiner Perkins & 24 others	72/100
3rd	Illumina 1993, San Diego (United States), Public	Developer of technologies for analysis of genetic variation and function	$28M	Chevron Technology Ventures, Dow Chemical Company ... & 32 others	71/100
4th	Complete Genomics 2006, San Jose (United States), Acquired	Developer of DNA sequencing platform for human genome sequencing and analysis	$125M	Enterprise Partners Venture Capital, Orbimed ... & 8 others	66/100
5th	QpiAI 2019, Bengaluru (India), Series A	Developer of integrated quantum computing hardware and artificial intelligence software	$54.1M	Famy Ananta, SIDBI Venture Capital & 39 others	63/100
6th	Ultima Genomics 2016, Newark (United States), Series D	Developer of high-throughput NGS instrument for research	$600M	General Atlantic, Lightspeed Venture Partners ... & 8 others	62/100
7th	S2 Genomics 2016, Livermore (United States), Acquired	Developer of automated sample preparation systems for genomics	$16M	Broadoak Capital Partners, RCT & 6 others	58/100
8th	Bionano 2002, San Diego (United States), Public	Provider of genome analysis solutions to researchers and clinicians	$124M	Battelle Ventures, Domain Associates & 17 others	58/100
9th	Algorithmiq 2020, Helsinki (Finland), Series B	Developer of quantum algorithms for chemistry and life science applications	$42.4M	United Ventures, Inventure & 12 others	57/100
10th	Singular Genomics 2016, San Diego (United States), Acquired	Provider of next-generation gene sequencing and multi-omics technologies	-	Perceptive Advisors, Domain Associates & 5 others	57/100
33rd	Quantum Biosystems 2013, Osaka (Japan), Series C	Developing DNA sequencers based on quantum mechanics	$35M	Mizuho Financial Group, UTEC & 5 others	39/100